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Abstract
Objective: To evaluate the effect of chlorhexidine-thymol varnish alone, its combination with chlorhexidine-fluo-
ride containing dentifrice and fluoride varnish on oral hygiene and caries prevention in orthodontic patients. 
Study design: Sixty patients, aged 12-18, with orthodontic fixed appliances were randomly assigned into three 
groups as follows: Group 1 (n=20): 1% chlorhexidine and 1% thymol varnish (Cervitec®Plus); Group 2 (n=20): 
Cervitec®Plus+ 0.2% chlorhexidine and 0.2% sodium fluoride (900 ppm fluoride) (Cervitec®Gel)); and Group 3 
(n=20): 0.1% fluoride varnish (Fluor Protector®). Mutans streptococci (MS), lactobacilli (LB) levels, buffering 
capacity (BC), visible plaque index (VPI), and gingival bleeding index (GBI) scores were evaluated at four stages: 
T0, before orthodontic bonding; T1, one week after orthodontic bonding; T2, one week; and T3, four weeks after 
the first application, respectively. Inter and intra group comparisons were made by the Kruskal-Wallis, Mann-
Whitney U, Friedman and Wilcoxon Signed-Rank tests with Bonferroni step-down correction (P<0.017). 
Results:  Significantly lower MS and LB levels were found in Group 2 than Group 1 (T2) and 3 (T2, T3) (P<0.017). 
Groups 1-2 (T2) showed significantly higher BC (P<0.017) and lower VPI and GBI (P<0.017) scores compared 
with Group 3. Decreased MS levels at T2 (P<0.017) and T3 (P>0.017) were found in Group1-2 compared with T0. 
Significantly lower LB levels were recorded in Group 2 at T2 compared with T0 (P<0.017) while no significant 
differences were seen in Group 1 and 3 (P>0.017).
Conclusions: Addition of Cervitec®Plus+Cervitec®Gel combination to the standard oral hygiene regimen may be 
beneficial for orthodontic patients for maintaining oral health by reducing bacterial colonisation and gingivitis.
Key words: Chlorhexidine, flouride, mutans streptococci, lactobacilli, antibacterial effect, plaque, gingivitis, 
orthodontic treatment.
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Introduction
Providing proper oral hygiene during fixed orthodon-
tic therapy is challenging. Fixed orthodontic appliances 
modify the oral flora and reduce the potential benefits 
of brushing and salivary flow on plaque (1,2). The in-
creased amount of plaque adjacent to bands and brack-
ets commonly results in poor oral hygiene and changes 
in the oral flora, including increased levels of Mutans 
streptococci (MS) and Lactobacilli (LB), increased 
plaque and bleeding scores, and reduced levels of buffe-
ring capacity (3-5). Insufficient removal of supragingi-
val plaque may cause development of white spot lesions 
and gingival diseases (3,6).
Preventive programs should be implemented to avoid 
the potentially detrimental  consequences of fixed or-
thodontic appliances in the oral environment (1). The 
application of antimicrobial therapies with common 
commercially produced antibacterial agents, such as 
varnishes, mouthwashes, or dentifrice gel formulations, 
particularly with chlorhexidine (CHX), have been found 
to be a beneficial preventive strategy for reducing unde-
sirable outcomes of fixed orthodontic appliances such 
as peridontal problems and white spot lesions (1,5,7). 
Several studies investigated the effects of various con-
centrations of chlorhexidine on oral microflora (1,4,8). 
It was shown that with a concentration as low as 0.2%, 
chlorhexidine is an effective antimicrobial agent to re-
duce Streptococcus Mutans levels in oral flora (4).
Chlorhexidine and thymol (Cervitec®Plus) combination as 
a varnish treatment was found to be beneficial in inhibit-
ing salivary MS levels and reducing gingivitis therefore 
improves oral hygiene in orthodontic patients (8,9-11). 
Chlorhexidine-based toothpastes as an adjunct to mechan-
ical cleaning facilitate the removal of plaque and providing 
better oral hygiene in orthodontic patients (1,10). 
Topical fluoride application by toothpastes, gels, rinses, 
and varnishes were found to be beneficial in patients with 
fixed appliances (6). However, a fluoride varnish regimen 
alone was postulated as an ineffective effort to improve 
oral hygiene status of orthodontic patients (11). 
Therefore, fluoride varnishes were suggested to be 
used in combination with other forms of fluoride sup-
plements (12). Additionally, a combined antimicrobial 
strategy with antibacterial agents and fluoride has been 
considered a more effective way to reduce possible 
caries-associated problems in orthodontic patients who 
undergo fixed appliance therapy (5). Moreover, a re-
cently developed gel formulation was introduced with 
a combination of 0.2% chlorhexidine and 0.2% sodium 
fluoride (Cervitec®Gel).
The main aim of this study was to investigate the anti-
bacterial effectiveness  of  chlorhexidine-thymol var-
nish (Cervitec®Plus) alone, its combination with chlo-
rhexidine-fluoride containing dentifrice (Cervitec®Gel) 
and fluoride varnish (Fluor Protector®) by measuring 
salivary Mutans streptococci and Lactobacilli levels 
and buffering capacity, visible plaque index and gin-
gival bleeding index scores in patients who underwent 
orthodontic fixed appliance therapy. 
Material and Methods
This research was designed as a prospective rand-
omized and blind clinical study. Individuals who were 
scheduled to start their fixed orthodontic treatment at 
the orthodontic clinic of Faculty of Dentistry, Karaden-
iz Technical University, were included. The patients or 
their parents were informed about the study and signed 
informed consent forms. Ethical approval was taken 
from The Karadeniz Technical University Ethics Com-
mittee before the study was initiated (2011/36). 
The selection criteria for inclusion in the study were as 
follows: Patients with complete permanent dentition, 
good general health and no use of pharmacotherapics 
for the last three months and aged between 12 to 18 at 
the initiation of fixed appliance therapy were included 
in the study. All the individuals underwent fully band-
ed, non-extraction edgewise treatment. There was no 
evidence of decalcification on the teeth. There was no 
known hypersensitivity to chlorhexidine and fluoride. 
No restorations on the anterior teeth were present. All 
volunteers presented a minimum level of pre-existing 
gingivitis and plaque.
Sixty patients were included in the study. Patients were 
advised to use fluoride-free dentifrice, toothbrushing 
and flossing for two weeks at home before bonding of 
the brackets. The bonding procedure was as follows: 
All buccal surfaces of the teeth to be bonded were 
pumiced with a rubber polishing cup using a low speed 
handpiece. Then the teeth were rinsed with water, air 
dried and etched with 37 % orthophosphoric acid for 
30 seconds. The acid was rinsed off and the teeth were 
dried until the enamel exhibited an ice frosted appear-
ance. Transbond XT primer (3M Unitek) was applied on 
the etched enamel surface and air thinned. Finally .022 
edgewise brackets were placed on the teeth with an ap-
propriate amount of Transbond XT (3M Unitek) applied 
on the bracket base. Excess adhesive around the brack-
ets was removed with a scaler and light cured for 15 sec-
onds with LED (Elipar Freelight 2, 3M Espe, Seefeld, 
Germany).  After bracket bonding, comprehensive oral 
hygiene instructions were given to the patients by the 
treating orthodontist (initials of the treating Ortho here 
probably OB).
Patients were randomly allocated into three groups
-Group 1 (n=20): 1% chlorhexidine diacetate and 1% thy-
mol (Cervitec®Plus, Ivoclar Vivadent, Schaan, Liechten-
stein). The individuals received a Cervitec®Plus varnish 
application one week after bonding of the brackets. 
-Cervitec®Plus application procedures were as follows: 
the tooth surfaces were cleaned thoroughly dried with 
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an air syringe and isolated with cotton rolls. Three 
drops of Cervitec®Plus were poured into a dappen dish. 
A thin coat of varnish was applied by means of a Vi-
vadent applicator on all of the surfaces of the bonded 
teeth (buccal, lingual, occlusal, and proximal areas). 
The varnish was dispersed with air and allowed to dry 
and the cotton rolls were removed after 30 seconds. Pa-
tients were instructed not to rinse, eat/drink or brush 
for one hour. They were also told to use fluoride-free 
dentifrices for four weeks at home. Parents were also 
told not to provide any other oral hygiene products. A 
paediatric dentist called the parents and children (every 
second day) to motivate them in order to provide valid 
participation in the trial.
-Group 2 (n=20):  1% chlorhexidine diacetate and 1% 
thymol (Cervitec®Plus Ivoclar Vivadent, Schaan, Liech-
tenstein) plus 0.2% chlorhexidine digluconate and 0.2% 
sodium fluoride (900 ppm fluoride), (Cervitec®Gel Ivo-
clar Vivadent, Schaan, Liechtenstein). The individuals 
received a Cervitec®Plus varnish application one week 
after bonding of the brackets. The application procedure 
of the Cervitec®Plus was the same as Group 1. After the 
application of the varnish, patients were told not to eat/
drink or brush for one hour. In this group, the patients 
were instructed to brush their teeth with Cervitec®Gel 
as a dentifrice for four weeks at home. They were in-
structed to brush their teeth three times a day for 2 min. 
Parents were also told not to provide any other fluoride-
containing dentifrices or oral hygiene products. 
-Group 3 (n=20): 5 wt% difluorosilane corresponding to 
0.7 wt% F-, (Fluor Protector®, Ivoclar Vivadent, Schaan, 
Liechtenstein). The individuals received a Fluor Protec-
tor® varnish application one week after bracket bonding. 
-Fluor Protector® application procedure was as follows: 
The tooth surface was cleaned thoroughly and dried 
with an air syringe and isolated with cotton rolls. A 
thin layer of Fluor Protector® was applied on all tooth 
surfaces (buccal, lingual, occlusal, and proximal ar-
eas) using a suitable single-use applicator (Vivabrush 
G). The varnish was dispersed with air and allowed to 
dry, and cotton rolls were removed after 60 seconds. 
Patients were instructed not to rinse their mouth. After 
the application of varnish, patients were told not to eat/
drink or brush for 45 minutes.  The patients were told 
to use fluoride-free dentifrices for four weeks at home. 
Parents were also told not to provide any other oral hy-
giene products. In order to assess plaque accumulation 
the following parameters were analysed: Salivary Mu-
tans streptococci (MS) and Lactobacilli (LB) levels and 
buffering capacity (BC), visible plaque index (VPI), 
and gingival bleeding index (GBI).
-Bacteria in saliva: CRT® bacteria (CRT® Intro Pack - 
Caries Risk Test, Ivoclar Vivadent, Schaan, Liechten-
stein) was used to determine the MS and LB count in 
saliva by means of selective culture media.
-CRT® bacteria procedure: Salivary secretion was stim-
ulated in the patients by chewing an enclosed paraffin 
pellet and saliva specimens were collected in a suitable 
container. The agar was removed from the test vial. A 
NaHCO3 tablet was placed at the bottom of the vial. The 
protective foils were carefully removed from the two 
agar surfaces. Both agar surfaces were wetted with sa-
liva using a pipette without scratching the agar surface. 
The test vial was placed upright in the incubator (Cul-
tura/ Ivoclar Vivadent Schaan, Liechtenstein) and incu-
bated at 37 °C/ 99 °F for 48 hours. After removal of the 
vial from the incubator, the density of the MS and LB 
colonies were compared with the corresponding evalu-
ation pictures in the enclosed model chart. Findings of 
105 CFU (colony-forming units) or more of MS and LB 
per ml saliva indicated a high caries risk (Fig. 1). 
-CRT® buffer procedure: Patients were instructed not 
to eat or drink anything, chew chewing gum, smoke, 
brush their teeth, or use any mouthwash for at least one 
hour before the test was conducted. The patients sat up-
right in a relaxed position. Salivation was stimulated 
by having the patient chew a paraffin pellet. The saliva 
was collected in a calibrated container. The entire yel-
low test field was wetted with saliva using a pipette. To 
determine the buffer capacity of saliva, the colour of the 
test field was compared with the colour samples after 
exactly five minutes of reaction time (Fig. 2).  
Fig. 1. CRT® bacteria (CRT® Intro Pack - Caries Risk Test, Ivoclar 
Vivadent, Schaan, Liechtenstein): Bright agar surface: determination 
of LB count in saliva, Blue agar surface: determination of MS count 
in saliva. The columns in the left indicated less than 105 CFU shows 
low caries risk and the columns in the right indicated more than 105 
CFU shows higher caries risk both for MS and LB per ml in saliva. 
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Fig. 2. CRT® buffer (CRT® Intro Pack - Caries Risk Test, Ivoclar Vi-
vadent, Schaan, Liechtenstein): Blue indicated a high, green indica-
ted a medium, and yellow indicated a low buffer capacity of saliva.  
-Plaque: The visible plaque index (VPI) was recorded 
as “1” for visible plaque and “0” for nonvisible plaque 
on the mesiobuccal surface of every bonded tooth af-
ter rinsing and drying the tooth surface. The number of 
surfaces with plaque was divided by the total number of 
examined surfaces.
-Gingivitis: The Gingival Bleeding Index (GBI) was as-
sessed by using a 0.5 mm diameter periodontal probe. 
The gingiva was lightly air-dried, and the probe was 
gently inserted into the gingival crevice parallel to the 
long axis of the tooth until slight pressure was felt. At 
this point, the probe was run along the crevice in con-
tact with the sulcular epithelium. Minimum axial force 
was used to avoid undue penetration into the tissue, and 
the probe was moved around the crevice, gently stretch-
ing the epithelium. Only the gingival margin at the me-
siolabial surfaces was evaluated for every bonded tooth. 
Bleeding was recorded as “1” and no bleeding as “0”. 
The number of elicited bleeding points was added up 
and divided by the number of sites probed. 
All of the above-mentioned recordings and measure-
ments were collected and/or measured by two expe-
rienced operators and assessor blinding was ensured 
throughout the trial period.  One of the examiners 
collected the saliva samples for bacteria and executed 
the buffering capacity procedures. This examiner per-
formed all of the procedures according to the instruc-
tions for CRT® bacteria and CRT® buffer procedures for 
an individual patient. He also recorded all of the meas-
urements for each stage of the study for each individual 
patient (T0, T1, T2, and T3). The other examiner meas-
ured the VPI and GBI values (T0, T1, T2, and T3).
Staining of the teeth and temporary bitter taste prob-
lems were also recorded. 
These parameters were evaluated at four different time 
points:
T0 (Baseline): The first samples and measurements were 
taken just before the bonding procedure. T1 samples and 
measurements were taken one week after bracket bond-
ing prior to varnish application. Also the varnishes were 
applied at this stage. T2 samples and measurements 
were obtained one week after application of varnish.T3 
samples and measurements were taken four weeks after 
application of varnish.
-Statistical analysis
Statistical analyses were performed with the statistical 
package SPSS 14.0 for Windows (SPSS Inc., Chicago, 
IL, USA). 
Age differences between groups were analyzed with 
one-way ANOVA and the gender differences were sub-
jected to the Chi-square tests at the significance level 
of P<0.05. 
Kruskal-Wallis and Mann-Whitney U tests with Bonfer-
roni step down correction for inter group comparisons 
was used. Intra group comparisons between the T0 and 
other periods (T0- T1, T0- T2 and T0- T3), were assessed 
by the Friedman and Wilcoxon Signed-Rank test con-
ducted with a Bonferroni correction. The significance 
level was set as P<0.017. 
Results
A total of 60 children were evaluated in this study. No 
significant differences were found among three groups 
regarding demographic properties (age, gender; P>0.05, 
Table 1). 
The inter and intra group comparisons are given in ta-
ble 2.
?
Group 1 Group 2 Group 3 
Gender  
(male/female) 
(%) 
8/ 12 
(40.0/ 60.0) 
11/ 9 
(55.0/ 45.0) 
11/ 9 
(55.0/ 45.0) 
Age (year) 
(mean±SD) 
(min/max)
15.75±2.22 
(12/18)
15.70± 1.92 
(12/18)
15.60± 2.16 
(12/18)
Table 1. Demographic variables (n).
*No significant differences were found between the groups regarding 
demographic variables gender and age (P>0.05) 
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?
Baseline (T>T0) T1 T2 T3
Parameters Group Mean ±SD Mean± SD Mean± SD Mean± SD 
MS 1
2
3
1.50±0.47A,a
1.35±0.48A,a
1.40±0.50A,a
1.55±0.51A,a
1.45±0.51A,a
1.75±0.44A,b
1.20±0.30A,b
1.00±0.10B,b
1.35±0.48A,a
1.20±0.41A,b
1.10±0.30A,b
1.30±0.47B,a
LB 1
2
3
1.35±0.48A,a
1.50±0.51A,a
1.50±0.51A,a
1.65±0.48A,a
1.45±0.51A,a
1.80±0.41A,a
1.40±0.50A,a
1.15±0.36B,b
1.65±0.48A,a
1.25±0.44A,a
1.00±0.10A,B,a
1.65±0.48C,a
BC 1
2
3
2.65±0.67A,a
2.65±0.58A,a
2.25±0.55A,a
2.85±0.36A,a
2.80±0.52A,a
2.40±0.59A,a
2.90±0.30A,a
2.85±0.36A,a
2.45±0.51B,a
2.90±0.30A,a
2.85±0.36A,a
0.50±0.51B,a
VPI 1
2
3
0.70±0.47A,a
0.65±0.48A,a
0.60±0.50A,a
1.00±0.00A,a
1.00±0.00A,a
1.00±0.00A,a
0.20±0.41A,a
0.10±0.05A,b
0.40±0.50B,a
0.15±0.36A,a
0.10±0.05A,b
0.20±0.40A,a
GBI 1
2
3
0.70±0.47A,a
0.65±0.48A,a
0.60±0.50A,a
1.00±0.00A,a
1.00±0.00A,a
1.00±0.00A,a
0.20±0.41A,a
0.10±0.05A,b
0.40±0.50B,a
0.15±0.36A,a
0.10±0.05A,b
0.20±0.41A,a
Table 2. Inter and intra group comparisons for all groups.
 * MS: Mutans streptococci , LB: Lactobacilli , BC: Buffering capacity ,VPI: Visible plaque index, GBI: Gingival bleeding index. 
** T0: Before orthodontic bonding, T1: One week after orthodontic bonding, T2: One week after the first application, T3: Four weeks after the first 
application.
*** In each column (each period), values with different superscript capital letters indicate significant differences (P<0.017), whereas same letters 
indicate no significant differences (P>0.017) between the control groups regarding individual parameters (MS, LB, BC, VPI and GBI) for inter 
group comparisons.
****In each row (for individual parameters), values with different superscript small caps indicate significant differences (P<0.017), whereas same 
letters indicate no significant differences (P>0.017) between the T0-T1,T0-T2 and T0-T3 periods for individual group for intra group comparisons.
-Intergroup Comparisons: No significantly different 
MS, LB, BC, VPI, and GBI levels were found at T0 and 
T1 among the groups (P>0.017). 
More prominent decrease was seen in Group 2 regard-
ing MS and LB levels than Group 1 (at T2) (P<0.017) 
and Group 3 (at T2 and T3, distinctly) (P<0.017). Group 
1 resulted in lower MS and LB levels compared with 
Group 3 but these were not significantly different at T2 
(P>0.017). Group 1 saw significantly decreased LB lev-
els at T3 compared with Group 3 (P<0.017).  
Groups 1 and 2 (at T2 and T3) (P<0.017) showed signifi-
cantly higher BC values compared with Group 3. 
Group 3 exhibited higher VPI scores compared with 
Groups 1 (T2; P<0.017, T3; P>0.017) and 2 (T2; P<0.017, 
T3; P>0.017).
Group 3 resulted in higher GBI scores compared with 
Groups 1 (T2; P<0.017, T3; P>0.017) and 2 (T2; P<0.017, 
T3; P>0.017).
-For Intragroup Comparison: In Group 1, MS levels sig-
nificantly decreased at T2 and T3 compared with at T0 
(P<0.017). Except for these comparisons, no significant 
differences were found between T0 and the other peri-
ods (T1, T2, and T3) with regard to MS, LB, BC, VPI, 
and GBI parameters (P>0.017).
In Group 2, MS levels significantly decreased at T2 and T3 
compared with T0 (P<0.017). LB levels also significantly 
decreased at T2 compared with T0 (P<0.017). Additionally, 
significantly lower VPI and GBI scores were found at T2 
and T3 compared with T0 (P<0.017). Except for these com-
parisons, no significant differences were found between T0 
and the other periods (T1, T2, and T3) with regard to MS, 
LB, BC, VPI, and GBI parameters (P>0.017).
In Group 3, MS levels significantly increased at T1 com-
pared with T0 (P<0.017). Except for these comparisons, 
no significant differences were found between T0 and 
the other periods (T1, T2, and T3) with regard to MS, LB, 
BC, VPI, and GBI parameters (P>0.017). 
Discussion
Fixed orthodontic appliances are known to have adverse 
affects on oral hygiene (8). Preventive measures such 
as good oral hygiene, noncariogenic dietary habits, and 
regular fluoride application should be carefully carried 
out throughout the treatment (7,8,13). Moreover, these 
attempts may not always be sufficient to avoid microbial 
colonization (7,8). Thus, adjunctive preventive applica-
tions i. e. applying chemotherapeutic agents, may be a 
key factor in reducing the potential risks of cariogenic 
microflora (7,14).
It is also important to provide better oral hygiene features 
by regular toothbrushing and flossing at home, particu-
larly for the orthodontic patient (14). Therefore, in addi-
tion to professionally applied varnish treatments (1,4,5,7), 
brushing teeth regularly with Cervitec®Gel formulations 
(with respect to its usage indications) and monitoring in 
four-week recall periods could be considered as an aver-
age interval follow-up period for patients in our study. As 
previously stated (14), home-based self-application treat-
Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 (2):e362-70.                                                                                                        Comparison of combined treatment with one visit varnish treatment 
e367
ments may decrease the plaque accumulation around the 
bands and brackets. Because of the above reasons, the 
short-term (T2, one week; T3, four weeks) combined ef-
fects of Cervitec®Plus+Cervitec®Gel (Group 2) formula-
tions were compared with one-visit varnish treatments in 
terms of MS, LB, BC, VPI, and GBI levels of orthodontic 
patients with fixed appliances.
This study demonstrated that combination therapy with 
Cervitec®Plus (one-visit application) and Cervitec®Gel 
(through toothpaste usage at home) is beneficial in re-
ducing salivary bacterial counts and improving oral hy-
giene features compared with one-visit Cervitec®Plus 
and Fluor Protector® applications in up to four weeks.
Increased levels of MS and LB were commonly found 
in the oral cavity after bonding orthodontic attachments 
(14). In this study, the CRT chair-side test was used 
to measure MS, LB, and BC levels. Different studies 
have also supported this method (15,16). Additionally, 
a significant correlation had been found between con-
ventional analysis with MSR agar and the MS or LB 
chair-site tests (17). To analyze the caries-associated pa-
rameters (MS, LB, and BC), a blind (had no idea about 
the treatment groups) experienced examiner conducted 
the test. This examiner collected all saliva samples and 
measured salivary bacterial counts and BC levels. VPI 
and GBI scores were presented as the key factors indi-
cating the oral hygiene status of the patients (8,10,12). 
Thus, in order to screen the oral hygiene features of the 
patients, another blind examiner (initials of the blind 
examiner) measured these parameters.
According to the initial MS and LB measurements of 
this study, the study group could be considered a high 
caries risk group (>105)  (15,16). However, T0 (baseline) 
and T1 values were not significantly different according 
to the MS, LB, BC, VPI, and GBI parameters among the 
groups (P>0.017). These findings could facilitate the 
data analysis among the groups, particularly at T2 and 
T3 periods. From this standpoint, undesirable individual 
responses to all treatments could be minimized. This is 
also concurrent with the randomly selected high caries 
risk group of the presented orthodontic clinic.  
Increased MS levels in saliva and around the bonded 
teeth had been reported three months after bonding (8). 
In this study, both MS and LB levels increased com-
pared with T0 values after the bonding period (T1), in 
all groups. This finding is consistent with the results of 
previous studies (7,8,14,16,17).
Fluoride treatment may be beneficial in eliminating the 
possible complications of fixed orthodontic treatment. 
However, a valid fluoride application regimen has not 
been described yet in terms of providing reasonable oral 
hygiene features in orthodontic patients (6). Previous 
reports indicated that fluoride and CHX combination 
therapy could be beneficial in increasing the bacterio-
static effect of fluoride (5,7,8).
Furthermore, commercially available tooth gel formula-
tions have been recommended to provide better oral hy-
giene features in patients undergoing orthodontic treat-
ments with fixed appliances (1). CHX-based gel formula-
tions have recently been found to decrease the gingival 
bleeding scores in patients with special care needs (18). 
However, the potential staining risk and temporary bitter 
taste of toothpaste formulations containing CHX must be 
carefully considered (19,20). In order to reduce the stain-
ing effect of CHX (1), reduce the concentration of CHX 
from 0.75% to 0.50% in dentifrice. They postulated that 
0.50% CHX reduces the staining risk without compro-
mising the its effectiveness against gingivitis and bleed-
ing. However, Sari et al. (4) showed that although 0.2% 
CHX reduces S. Mutans levels, it does not have any ef-
fect on Lactobacillus count in saliva. Nevertheless, man-
ufacturer instructions indicate that using Cervitec®Gel 
formulation for about four weeks can help avoid possi-
ble side effects, including staining of the teeth and tem-
porary bitter taste problems. No staining or temporary 
bitter taste problems were recorded in this study. One-
visit varnish treatment model was used to compare the 
potential use of CHX tooth gels over longer periods and 
to observe the exact desirable or undesirable effects of 
combined therapies for future studies. 
The most common preventive application during fixed 
orthodontic treatments was repeated varnish treatments 
in different time intervals (8,14). Various varnish treat-
ment procedures and frequencies have been document-
ed in the literature regarding the use of Cervitec®Plus 
or fluoride varnishes in orthodontic patients (7,8,21). 
Moreover, fluoride varnish treatments were found to re-
duce salivary bacterial counts and decrease the plaque 
index and bleeding scores (22). Possible positive effects 
of applying repeated varnish treatments documented 
in the literature were reducing bacterial counts and 
plaque scores (2,7,8,21). However, findings which in-
dicate that repeated applications did not always result 
in better antimicrobial suspension or acceptable oral 
hygiene features with evidence of long-term outcomes 
cause controversies (2,5). Previous findings revealed 
that MS suppression could persist after a single appli-
cation of CHX-containing varnish for two weeks (21), 
three weeks (14), or six months (23). Additionally, such 
investigation designs or methodologies clearly showed 
that varnish treatment with CHX or therapeutic fluoride 
materials was used in various ways either before (inten-
sive) or after the bonding procedures (7,8,21). 
Moreover, an effective way to apply varnish immediately 
after the bonding procedure was found to be a main con-
cern (21,24). Furthermore, in this study, because one-vis-
it application procedures and combined therapy (to avoid 
the side effects of self application of CHX gel formulation) 
were utilized for short follow-up periods, an intensive ap-
plication period was not used. However, if varnishes are 
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used before bonding, similar to previous study designs 
(1,10), negative microflora alterations after the bonding 
procedure (T1) and the effect of combined therapy might 
be concealed since the varnishes could have a prolonged 
cumulative antimicrobial effect up to the T2 and T3 peri-
ods. In this way, the study aimed to evaluate the short-
term effectiveness of combination therapy over one-visit 
varnish treatment models in a dental clinic, particularly 
after the bonding procedure. 
Regarding intergroup comparisons, MS and LB levels in 
Group 2 decreased significantly better than Groups 1 (at 
T2) (P<0.017) and 3 (at T2 and T3, distinctly) (P<0.017). 
This evidence showed that the self-application of tooth 
gel formulation could increase the success of one-visit 
varnish treatments. This feature might be attributed to 
remaining CHX particles around negatively ionized 
tooth surfaces with regular tooth brushing (1,7,8,10,23). 
This study also confirmed that one-visit application of 
CHX-based varnishes (Group 1) showed better antimi-
crobial properties over the fluoride (Group 3) varnish 
treatments, as previously described (8,10,11). The lim-
ited/biased factor of Group 2 should also be taken into 
account, as it had a potential advantage since the home-
based self-application of Cervitec®Gel could increase 
treatment success over professionally applied varnishes 
in terms of providing acceptable oral hygiene features. 
Furthermore, since the short-term present outcomes of 
varnish treatments (in Groups 1 and 3) were found to 
be less successful, sealing all areas with the varnishes 
should not be overlooked since a great deal of care was 
declared, as previously noted (25). 
Nonetheless, the application of varnish treatments (in 
Groups 1 and 3) could be almost difficult when high vis-
cosity features of these agents clearly obstruct their po-
tential usage around bands and brackets after bonding 
procedures (24). The possible failure problems related 
to varnish treatments were documented as rapid recolo-
nization and returning of MS bacteria to baseline levels 
(2,7,8,16,17,21) . In this study, Group 1 and, in particu-
lar, Group 2 exhibited significantly lower (P<0.017) MS 
levels in saliva at T2 and T3 compared with individual 
T0 values. Moreover, in Group 3, the lower but insig-
nificant (P>0.017) MS levels were found at either T2 or 
T3 compared with individual T0 values. Considering LB 
bacteria, such differences were found compared with 
MS. Group 1 and, in particular, Group 2 exhibited lower 
but insignificant (P>0.017) LB levels compared with T0 
values. Also, in Group 3 the LB levels were found almost 
higher at T2 and T3 compared with individual T0 values 
(P>0.017). After the varnish treatments, the chosen test 
periods (T2, one week and T3, four weeks) could also 
reflect risk of recolonization since this problem could 
be observed at about two weeks (21). These periods 
(one week and four weeks) may be considered worst-
case scenario conditions for all groups. Therefore, after 
observing the above findings, the rapid bacterial recolo-
nization feature is understandably more risky in Group 
3 than in Groups 1 and 2, respectively (Table 2). These 
findings may also be gained from the acceptable intra-
group variations of the tested groups, which simplified 
screening of the effectiveness of therapeutic approaches 
and increased the power of the present study. 
After application of the fixed orthodontic appliances, 
the destructive effect could be minimized only with the 
BC of the saliva. Moreover, the metallic bracket features 
have been shown to induce specific changes in the oral 
environment (26). In this study, the BC was found higher 
in Groups 1 and 2, and significantly different during T2 
and T3 (P<0.017) compared with Group 3. Also, Group 2 
exhibited higher BC values at T2 and T3 (P>0.017) com-
pared with Group 1. These findings highly extrapolated 
that the use of a combined therapy would be beneficial, 
particularly during the early stages of the fixed orthodon-
tic treatment. Recommending home-based CHX con-
taining tooth gel formulations with professional varnish 
therapies seemed to improve oral hygiene features as 
shown by the BC results of this study. 
Since increased plaque accumulation and gingival 
bleeding are known as possible side effects of fixed 
orthodontic treatments (27), this study also evaluated 
VPI and GBI values. Bonding teeth with metallic ap-
pliances increases plaque accumulation and gingival 
bleeding (28). In this study, the VPI and GBI scores 
tended to increase at T1 (immediately after bonding) 
compared with T0 for all groups (P>0.017), consistent 
with previous findings (29). Group 3 exhibited higher 
VPI and GBI scores compared with Groups 1 and 2 at 
T2 (P<0.017) and T3 (P>0.017). For Group 1, a posi-
tive effect was found, consistent with previous findings 
(10,29,30). Group 2 also experienced lower plaque accu-
mulation and bleeding problems compared with Group 
1 (P>0.017) at T2 and T3. In addition, in Group 2 the 
VPI and GBI scores were also found significantly lower 
at T2 and T3 compared with T0 (P<0.017). Considering 
all of the parameters, the possible beneficial effects of 
combined therapy over one-visit varnish applications 
(Groups 1 and 3) verified by the decreasing VPI and 
GBI results found in this study. Previous findings re-
vealed that six or 12-weeks application of low concen-
trated CHX-based tooth gel formulations (0.50%) might 
be beneficial in reducing plaque accumulation and gin-
gival bleeding without considering side effects such as 
staining and bitter taste  during orthodontic treatment 
(1).  In this study, reduced concentration of CHX (0.2%) 
tooth gel formulation with 0.2% sodium fluoride was 
used in a self-application procedure and was also found 
to be a promising agent for the prevention of decalcifica-
tion in orthodontic patients. Findings of this study are 
in agreement with the previous CHX-based toothpaste 
studies (10). Although the one-visit varnish treatment 
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procedure could increase the effectiveness in Group 2 
compared with Group 1, the relatively beneficial pro-
longed effect of the present results at T3 of this study 
showed that Cervitec®Gel formulation could be a part 
of routine oral hygiene in orthodontic patients. From an-
other perspective, further investigations are needed on 
a more frequent, home-based self-application procedure 
combined with repeated varnish treatments over a long 
evaluation period. 
The measured parameters being better in Group 2 than 
Groups 1 and 3 may also be explained by the Hawthorne 
effect. Children were highly motivated when they were 
told to brush their teeth with the specific gel formula-
tion in Group 2. Thus, recommending home-based pre-
ventive applications instead of routine toothbrushing 
practices in different time intervals could be useful in 
motivating children undergoing fixed orthodontic treat-
ment. This may have been a confounding factor, as pre-
viously described (10). 
Overall, within the limitations of this study, the combina-
tion of  chlorhexidine varnish and chlorhexidine-fluoride 
containing dentifirice  was found to be a successful and 
promising alternative for improving oral hygiene features 
of patients lacking sufficient oral hygiene characteristics 
during orthodontic treatment. Moreover, the possible side 
effects of toothpastes must be carefully monitored and, if 
required, eliminated by the clinician (1,10).
One-visit chlorhexidine varnish treatment combined 
with a home-based chlorhexidine-fluoride gel formula-
tion may be implemented as a caries prevention strat-
egy, for patients undergoing fixed appliance treatment 
and particularly under high risk of caries. 
Further studies are needed to evaluate long-term effec-
tiveness of repeated preventive procedures. 
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